1. Circulating tumor DNA is a sensitive marker for routine monitoring of treatment response in advanced colorectal cancer. (21st September 2020) Authors: Zou, Donghui; Day, Robert; Cocadiz, Judy A; Parackal, Sarah; Mitchell, Wilson; Black, Michael A; Lawrence, Ben; Fitzgerald, Sandra; Print, Cristin; Jackson, Christopher; Guilford, Parry Journal: Carcinogenesis Issue: Volume 41:Number 11(2020) Page Start: 1507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗